Effects of inhibiting RhoA by Stealth RNA on high glucose-induced RhoA/ROCK signaling pathway in human mesangial cells

National Medical Journal of China

Volumn 91, Issue 20, 2011, Pages 1417-1421

  Ma, Dong Wei ^a   Wang, Qiu Yue ^a   Chen, Qi Guang ^b   Wu, Dan ^b   Wang, Jiao ^a   Hou, Lu Lu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Mesangial cells; rhoA GTP binding protein; RhoA ROCK signaling pathway; RNA interference

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GLUCOSE; LIPOFECTAMINE; MESSENGER RNA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; CTGF PROTEIN, HUMAN; RHO KINASE; RHOA PROTEIN, HUMAN; ROCK1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL LINE; GENETICS; MESANGIUM CELL; METABOLISM;

CELL LINE; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTINS; GLUCOSE; HUMANS; MESANGIAL CELLS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870261225     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.20.013     Document Type: Article

References (14)

1. Shiokawa S, Iwashita M, Akimoto Y, et al. Small guanosine triphospatase RhoA and Rho-associated kinase as regulators of trophoblast migration. J Clin Endocrinol Metab, 2002, 87: 5808-5816.
2. Peng F, Wu D, Gao B, et al. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes, 2008, 57: 1683-1692.
3. Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth factor-betal expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol, 2000, 11: 80-87.
4. Martinez Castelao A. Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk. Nefrologia, 2008, 28(Suppl 5): 79-84.
5. Jo M, Thomas KS, Somlyo AV, et al. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem, 2002, 277: 12479-12485.
6. Hall A. Rho GTPases and the actin eytoskeleton. Science, 1998, 279: 509-514.
7. Miao L, Calvert JW, Tang J, et al. Upregulation of small GTPase RhoA in die basilar artery from diabetic (mellitus) rats. Life Sci, 2002, 71: 1175-1185.
8. 2008, 23: 800-805.
9. Tijsterman M, Plasterk RH. Dicers at RISC: the mechanism of RNAi. Cell, 2004, 117: 1-3.
10. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature, 2004, 428: 431-437.
11. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296: 550-553.
12. Caplen NJ. Gene therapy progress and prospects downregulating gene expression: the impact of RNA interference. Gene Ther, 2004, 11: 1241-1248.
13. Elbashir S M, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured manmmalian cells. Nature, 2001, 411: 494-498.
14. 2007: 100-105.